Pilot Study PBSCT With TCRab Depletion For Hemoglobinopathies
Part of paid clinical trials in Philadelphia, Pennsylvania.
- Sponsor
- Timothy Olson
- Study ID
- NCT04523376
- Status
- Completed
Conditions
- Sickle Cell Disease
- Thalassemia Major
Eligibility Criteria
- Sex
- ALL
- Age
- 2 Years - 25 Years
- Healthy Volunteers
- Not accepted
Interventions
- CliniMACS — DEVICEPeripheral blood stem cells from closely matched unrelated donors will be processed using the CliniMACS device to remove TCRalpha/beta T cells and B cells, in accordance with the Investigator Brochure and Technical Manual following the laboratory standard operating procedures (SOPs) and using aseptic technique
Study Details
This is a single arm pilot study of peripheral stem cell transplantation (PSCT) with ex vivo t-cell receptor alpha beta+(TCRαβ+) T cell and cluster of differentiation 19+ beta (CD19+ B) cell depletion of unrelated donor (URD) grafts using the CliniMACS device in patients with sickle cell disease (SCD) and beta thalassemia major (BTM).
Key Dates
- Start date
- May 14, 2020
- Status verified
- Mar 2026
- Primary completion
- Jun 23, 2025
- Completion
- Oct 1, 2025
Study Design
- Enrollment
- 8 participants (actual)
- Allocation
- NON_RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Sickle Cell DiseasePatients with Sickle Cell Disease (SCD) will be given previously established, disease-specific chemotherapy based conditioning regimens prior to hematopoietic stem cell transplantation using TCRalpha/beta and B cell depleted peripheral blood stem cells from closely matched unrelated donors.
- Experimental: Beta Thalassemias MajorPatients with Beta Thalassemias Major (BTM) will be given previously established, disease-specific chemotherapy based conditioning regimens prior to hematopoietic stem cell transplantation using TCRalpha/beta and B cell depleted peripheral blood stem cells from closely matched unrelated donors.
Primary Outcome Measure
Rate of Graft Failure [ Time Frame: Up to 1 year post-transplantation ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Children's Hospital of Philadelphia | Philadelphia | Pennsylvania | 19104 | - |
Find similar trials in Philadelphia, PA
By condition
By research site
Related Studies
- Effect of MitoQ on Platelet Function and Reactive Oxygen Species Generation in Patients With Sickle Cell AnemiaRecruiting · University of Pittsburgh · Pittsburgh, Pennsylvania
- A Long-term Follow-up Study in Participants Who Received CTX001PHASE3 · Enrolling By Invitation · Vertex Pharmaceuticals Incorporated · Palo Alto, California
- ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic DisordersRecruiting · American Thrombosis and Hemostasis Network · Phoenix, Arizona
- Long-term Follow-up of Subjects with Sickle Cell Disease Treated with Ex Vivo Gene TherapyEnrolling By Invitation · Genetix Biotherapeutics Inc. · Birmingham, Alabama